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Abstract
Background: If trained, equipped and utilised, community health workers (CHWs) delivering integrated community
case management for sick children can potentially reduce child deaths by 60%. However, it is essential to maintain
CHW motivation and performance. The inSCALE project aims to evaluate, using a cluster randomised controlled
trial, the effect of interventions to increase CHW supervision and performance on the coverage of appropriate
treatment for children with diarrhoea, pneumonia and malaria.
Methods/Design: Participatory methods were used to identify best practices and innovative solutions. Quantitative
community based baseline surveys were conducted to allow restricted randomisation of clusters into intervention
and control arms. Individual informed consent was obtained from all respondents. Following formative research
and stakeholder consultations, two intervention packages were developed in Uganda and one in Mozambique. In
Uganda, approximately 3,500 CHWs in 39 clusters were randomised into a mobile health (mHealth) arm, a
participatory community engagement arm and a control arm. In Mozambique, 275 CHWs in 12 clusters were
randomised into a mHealth arm and a control arm. The mHealth interventions encompass three components: 1)
free phone communication between users; 2) data submission using phones with automated feedback, messages
to supervisors for targeted supervision, and online data access for district statisticians; and 3) motivational messages.
The community engagement arm in Uganda established village health clubs seeking to 1) improve the status and
standing of CHWs, 2) increase demand for health services and 3) communicate that CHWs’ work is important.
Process evaluation was conducted after 10 months and end-line surveys will establish impact after 12 months in
Uganda and 18 months in Mozambique. Main outcomes include proportion of sick children appropriately treated,
CHW performance and motivation, and cost effectiveness of interventions.
Discussion: Study strengths include a user-centred design to the innovations, while weaknesses include the lack of
a robust measurement of coverage of appropriate treatment. Evidence of cost-effective innovations that increase
motivation and performance of CHWs can potentially increase sustainable coverage of iCCM at scale.
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Background
During the last decade, child mortality has been reduced
significantly in a number of African countries. However,
preventable illnesses such as diarrhoea, pneumonia and
malaria are still claiming almost 2 million lives in new-
borns, infants and children under five years of age [1].
Scaling up interventions that increase access to timely
and appropriate treatment at the community level could
prevent more than 60% of these deaths [2]. As a way of
increasing access to treatment for sick children, several
African countries are investing in community health
workers (CHWs) as a cost-effective way of extending
health services to people living beyond the reach of the
health facilities. Integrated community case management
(iCCM) is a delivery strategy that utilises CHWs to diag-
nose and treat multiple conditions, most commonly pneu-
monia, diarrhoea and malaria, in children under five [3]. If
properly trained, equipped and utilised, CHWs have the
potential to reduce child deaths substantially by increasing
access to timely, appropriate and affordable treatment for
poor and rural populations [4].
CHW programmes have been faced with the challenge
to scale up with high CHW attrition rates and substandard
care quality. This has largely been due to problems with
poor planning; fragmented and disease-specific training;
tenuous linkage to the health system; poor coordination,
supervision and support; and under-recognition of CHWs’
contribution to the health system [5,6]. If CHW pro-
grammes are to reach their potential, there is an urgent
need for strategies that improve performance, motivation
and retention of CHWs [7-9]. This paper presents a proto-
col for a cluster randomised controlled trial (cRCT) con-
ducted under the inSCALE project (Innovations at Scale
for Community Access and Lasting Effects). inSCALE
aims to enhance the motivation and performance of
CHWs in order to ultimately increase the coverage of
children who receive appropriate treatment for diarrhoea,
pneumonia and malaria in Uganda and Mozambique.
Methods/Design
Study aim and objectives
The aim of this study is to develop and evaluate innovative
approaches for increasing CHW supervision, motivation,
performance and retention, and assess the impact of these
interventions on coverage of appropriate treatment for
children with diarrhoea, pneumonia and malaria in
Uganda and Mozambique.
Primary objectives
Formative phase
The primary objectives during the formative phase of
this study are as follows:
1. To identify innovative solutions with the potential to
increase coverage of iCCM and improve its quality
through better CHW performance, motivation and
retention.
2. To assess the feasibility of these innovative solutions
and assess their acceptability among community
members, CHWs, facility-based health workers,
sub-national and national health authorities.
Evaluation phase
The primary objectives during the evaluation phase of
this study are as follows:
1. To evaluate the impact of the selected interventions
on CHW performance, motivation, retention, and
coverage of appropriate treatment for children with
diarrhoea, pneumonia and malaria.
2. To assess the costs of the interventions and
investigate their potential cost-effectiveness.
Dissemination phase
The primary objective during the dissemination phase of
this study is as follows:
1. To promote the implementation and spread of
iCCM by sharing with the Ministry of Health (MoH),
sub-national health authorities and stakeholders the
experiences and findings that improve coverage and
quality of iCCM.
Study context
The inSCALE study is collaboration among Malaria
Consortium, the London School of Hygiene & Tropical
Medicine, the Institute of Global Health at University
College London, Karolinska Institutet, Makerere Univer-
sity College of Health Science and the Ministries of Health
(MoH) in Uganda and Mozambique. inSCALE has been
implemented in the Midwestern region of Uganda and in
Inhambane Province in Mozambique. Both Uganda and
Mozambique have a long history of implementing com-
munity case management for sick children.
Uganda was one of the first countries to scale up home
management of Malaria from 2002 to 2006, introducing
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pre-packed chloroquine-sulphadoxine/pyrimethamine for
presumptive treatment of fever by volunteer CHWs. In
2004, after the rebel war, UNICEF supported the MoH to
pilot the implementation of home-based care of children
with diarrhoea, pneumonia and malaria in Northern
Uganda using oral rehydration solution (ORS), cotrimoxa-
zole and artemether-lumefantrine (Coartem; Novartis).
Beginning in 2006, the MoH instituted the Village Health
Team (VHT) strategy to strengthen community capacity
for health promotion and health service delivery. A VHT
has 4 to 5 volunteers (referred to as ‘VHTs’) selected by
the community and equipped with basic materials (storage
boxes, badges, T-shirts and gumboots). In 2010, Uganda
launched iCCM, whereby two community-elected VHTs
per village were trained to manage children 2 to 59 months
with malaria, pneumonia, and diarrhoea using diagnostics
(malaria rapid diagnostic tests (mRDTs) and respiratory
timers for detection of fast breathing) and treatment (dis-
persible artemether-lumefantrine, dispersible amoxicillin,
ORS, zinc and rectal artesunate). These VHTs also carry
out home visits for active case detection and referral of
sick newborns. Children with severe malaria and pneumo-
nia are given pre-referral treatment with rectal artesunate
and amoxicillin, respectively. The VHTs are supervised by
health workers from the nearest health facility who con-
duct quarterly supervision group meetings at the health
facility, at which time the VHTs also replenish their medi-
cine stocks. A transport refund of about US$ 4 is given to
VHTs at these meetings. Health workers supplement
group meetings at health facilities with monthly commu-
nity visits to VHTs during the first 3 months after training
[10] and subsequently on at least an annual basis.
In Mozambique, the MoH introduced the concept of
the lay CHW through the ‘Agente Polivalente Elementar’
(APE) in the 1970s to support public health activities at
the district level [11]. The programme, which was ini-
tially very strong despite implementation challenges,
weakened in the 1980s due to a shift in focus in the
health sector: from provision of primary health care at
the community level to provision at the facility level,
partly influenced by system breakdowns during the civil
war. Some of the original APEs still continued to work,
but a lack of supervision, re-training and effective integra-
tion into the health system resulted in low programme
effectiveness. In 2007, the MoH held a national level meet-
ing to refocus the roles and responsibilities of the APEs,
and in 2010 the Minister endorsed the APE operational
plan and revised curriculum [12]. Recommendations
highlighted that APEs should be respected and trusted
individuals selected by their community and trained by
the MoH to promote better health within their community
and provide preventive and curative care. They receive Kit
C - a basic medicine kit including ORS and zinc for diar-
rhoea, amoxicillin for pneumonia, artemether-lumefantrine
for uncomplicated malaria, and pre-referral rectal artesu-
nate for children with severe malaria. In 2013, mRDTs and
adult artemether-lumefantrine were also provided in a sep-
arate kit from the National Malaria Control Programme.
The APEs diagnose, refer, and treat children between 2 and
59 months of age for diarrhoea and pneumonia, as well as
all age groups with confirmed malaria. Guidelines recom-
mended that the majority of their time (80%) should be
spent in the communities doing house-to-house visits,
holding health education talks (‘palestras’), and conducting
active case detection and referral of sick newborns and
pregnant women. As per the APE programme guideline,
the APEs receive quarterly supervision from the nearest
health facility (when medicine kits are replenished) in
addition to six-monthly supervision by outreach teams
from the district. APEs receive a monthly allowance of 60%
of the minimum salary level (US$ 40).
Study sites
inSCALE Uganda
inSCALE operates in eight districts in Midwestern
Uganda (Buliisa, Masindi, Kibaale, Kyegegwa, Kyankwazi,
Kiryandongo, Kiboga and Hoima), where iCCM imple-
mentation has been supported by the Malaria Consortium
through a grant from the Canadian International Develop-
ment Agency (CIDA) since August 2010 (Figure 1). Under
the CIDA grant, Malaria Consortium provides technical
support to the programme design; trains Master and dis-
trict trainers; facilitates the training of VHTs; supplies
health facilities and VHTs with medicines; and supports
health facilities and districts to do monitoring and evalu-
ation as well as supportive supervision. The districts where
the projects have been implemented have an estimated 1.8
million people living in approximately 4,000 villages, with
20% being children under 5 years of age. The population
is multiethnic and has a variety of cultural practices, with
the majority of the population being able to read and
write. It includes nomadic cattle herders, fishing commu-
nities, and peasant farmers. In the area, approximately
10,000 VHTs are operating, with 5,700 VHTs (approxi-
mately two per village or 1 per 250 people on average)
trained in iCCM for 6 days between July 2010-June 2011.
Each VHT sees, on average, 14 children every month [13].
inSCALE Mozambique
inSCALE operates in all 12 districts in Inhambane
Province (Funhalouro, Govuro, Homoíne, Inharrime,
Inhassoro, Jangamo, Mabote, Massinga, Morrumbene,
Panda, Vilankulo, and Zavala). Since 2011, iCCM imple-
mentation in seven of these districts was supported by Mal-
aria Consortium, while UNICEF supported the other five
(Figure 2). Under the same CIDA grant as for Uganda, the
Malaria Consortium supported the revisions of the training
manuals and job aids for the APEs; the implementation of
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the 4 months training; the provision of APE medicines to
the provincial warehouse; and the implementation of
supervision and monitoring and evaluation activities. The
province and districts where the programmes were imple-
mented have an estimated 1.3 million people living in
approximately 145 villages (bairros), with 18% being
children under 5 years of age. There are three ethnic groups
whose constituents communicate mostly in Portuguese
(the official language in Mozambique), Chope (the southern
part of Inhambane) and Matsua (the northern part of
Figure 1 inSCALE implementation area in Midwestern Uganda.
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Figure 2 inSCALE implementation area in Mozambique.
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Inhambane). The majority of the population are subsistence
farmers with little or no literacy skills. In the province, 275
APEs were trained between August and December 2011 in
the new curriculum, which includes a module of iCCM.
Each APE serves approximately 500 to 2,000 people and
sees, on average, 50 patients every month.
The inSCALE interventions
inSCALE developed two integrated intervention packages
based on extensive formative research [14-16]. At the be-
ginning of the project, several reviews and consultations
took place to ensure that the interventions designed drew
on experience from previous work and appropriate theory.
There was an additional focus on using these sources to
identify areas of legitimate need with genuine potential for
innovation. An initial team meeting determined what to
review with three strands of enquiry identified and de-
scribed below, and tasks were allocated to team members
with relevant expertise, written up in reports [17] and pre-
sented and discussed in subsequent meetings:
1 Literature reviews of the areas of supervision,
motivation theory, incentives, data use in quality
improvement, mobile health (mHealth), business
management and human resources, agriculture and
community development.
2. Reviews of the history of Uganda and Mozambique
as it relates to CHW programmes.
3. Consultations with stakeholders, academic and
programme implementers working with health-
focused CHWs in a variety of contexts to identify
strategies that could increase CHW motivation and
retention.
These reviews were used to inform the development of
a conceptual framework on CHW motivation to perform
and remain in role and to develop a list of potential al-
ternative solutions to these problems - called ‘innova-
tions’. Using the reviews and the theoretical findings, the
inSCALE team selected a ‘long list’ of potential innova-
tions to test based on ratings for a) impact potential, b)
ability to fulfil required needs (in relation to CHW mo-
tivation and performance), c) acceptability, d) feasibility
and e) sustainability. The long list of innovations fell into
two clusters: a mHealth arm and a participatory commu-
nity engagement arm. Both of these approaches aimed
to positively influence CHW motivation, retention and
performance by promoting their sense of collective
identity.
The long list of potential innovations was presented to
key personnel at the MoH in each country who gave
their feedback on feasibility, acceptability and impact
using pile sorting methodology [18], the results of which
were used to eliminate several innovations felt to be
unfeasible or unacceptable. Consequently, a list was cre-
ated of 15 potential activities identified across the two
intervention packages in the two countries. Formative
research, gauging views of CHWs, their supervisors, dis-
trict officials and key programme implementers, as well
as caregivers, heads of households and traditional com-
munity leaders, was then conducted to ensure that inno-
vations were acceptable and feasible at the community
level, filled a need, and to determine the details of the
approach (Strachan DL, Källander K, Nakirunda M,
Ndima S, Muiambo A, Hill Z for the inSCALE study
group, unpublished paper). Data were also collected on
the current work of the CHWs and support that they re-
ceived in order to understand motivation and retention
and to identify priority issues. The results were used to
finalise the two intervention packages. These consisted
of a number of innovations (Figure 3) with both inter-
vention packages implemented in Uganda and one in
Mozambique [15]. Materials developed to support these
packages were extensively reviewed and pre-tested.
Intervention package 1 - The participatory community
engagement approach
In Uganda, the inSCALE project is supporting the im-
plementation of an innovative participatory community
engagement approach called the Village Health Clubs
(VHCs). The VHC aims to improve child health through
a community-led forum with the CHWs as the main
focus point. VHC meetings are intended to provide a
forum where CHWs and community members who are
part of the club can work together to identify child
health and CHWs challenges. They use village networks,
knowledge, creativity and other community assets to
help solve child health problems. Village health clubs are
implemented through a four-step learning, planning and
action cycle facilitated by the CHW. The time between
each step is 1, 2 or 4 weeks depending on the decision
taken by the club members. Health club members rank
child health challenges faced by their community using
picture cards. They discuss solutions, which include sup-
porting the functioning of CHW services, and take actions
to meet these challenges. Throughout the cycle the health
clubs monitor and report on their progress.
Village health clubs are open to all members of the
village and designed to be fun while focusing on the
CHW as the main village health asset. A participatory
empowerment approach is adopted where the CHW (as
facilitator) encourages members to plan and carry out
the club’s activities. They also promote group decision-
making and ownership. Solutions to village health chal-
lenges developed by village members are a key focus of the
village health club approach. Table 1 describes the contents
of the participatory community engagement intervention
in Uganda.
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Intervention package 2 - the mHealth supported approach
In Mozambique and Uganda, inSCALE is giving CHWs
phones with which they can send their weekly reports,
receive immediate automated feedback on performance
and access a closed user group with their supervisors in
order to increase communication and support. Every
month, a motivational performance-related SMS is sent
out, and supervisors receive weekly automated action-
able messages for CHWs who are performing at high or
low standards. Table 2 describes the components of the
mHealth intervention arm for Mozambique and Uganda.
Supportive activities
Several supportive actions took place to promote the
interventions before their introduction in the commu-
nities. In both countries, consensus dialogue meetings on
the planned interventions, the randomisation process and
the evaluation of the RCT were organised with local
leaders, using printed sensitisation briefs and presenta-
tions. In Uganda, meetings were held with district and
sub-county leaders, and in Mozambique, two sensitisation
meetings were held with provincial and district leaders.
After these meetings, the districts and sub county leader-
ships (Uganda) and provincial and district stakeholders
(Mozambique) pledged their support towards the inter-
ventions and approved the forthcoming randomisation
process.
Effect pathways of inSCALE’s interventions
Figure 4 outlines the conceptual framework for the
evaluation of the inSCALE interventions and how they
link to the main outcomes. Both interventions assume
that motivation is the key to performance and retention,
and that when these improve, the result will be im-
proved access to services and, ultimately, improvements
in appropriate treatment of sick children. The mHealth
supported approach, using mobile phones with unlim-
ited talk time and custom-made applications, is intended
to improve the CHWs’ sense of connectedness to the
health system and to their CHW peers. As a result of
the increased support and performance-related feedback,
it is hoped that the CHWs will feel an improved sense of
Figure 3 Details of inSCALE’s two integrated intervention packages.
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status. The free talk time is expected to enable supervi-
sors to provide targeted supervision, while the reminder
messages and respiratory timers are meant to improve
performance in diagnosis, treatment and referral. In
Mozambique, the CHW performance was explored dur-
ing the formative phase and was found to be lower than
in Uganda, presumably because of the lack of effective
job aids. Therefore, additional multimedia phone soft-
ware was developed for Mozambique, which provides
the CHW with a step-by-step guide to the consultation
steps as well as treatment guidance when all steps are
complete.
Table 1 Content of the participatory community engagement intervention in Uganda
Intervention components Uganda
Key principles Village health clubs (VHCs) aiming to improve child health through a community led-forum with the village
health team (VHT) as the main focus point.
Based on five main pillars:
• open to all
• village owned
• intended to support VHT work
• strength based (using village assets), and
• fun and focused
Training and club facilitation Two VHT club facilitators from each village trained for four days to encourage club members to plan and carry
out the club’s activities using an action and planning cycle.
Accessories and materials • Picture cards for ranking common child health problems
Instructional VHC flip books
• T-shirts
• Membership cards
• Stamps and other stationary to help with the establishment and operation of the clubs in the communities
Supervisor support and patrons Village leaders were appointed as patrons and sensitised to support the mobilisation of the communities to join
the clubs.
VHT supervisors, health assistants and sub-county development officers were trained by District Health Educators
and Malaria Consortium master trainers in effective supervision skills using a core competency assessment tool,
and as trainers of VHTs in the VHC intervention.
Numbers of users A total of 880 VHTs across the eight districts, to facilitate the set-up of 440 VHCs.
Table 2 Content of the mHealth intervention in Mozambique and Uganda
Intervention
components
(‘innovations’)
Mozambique Uganda
Mobile phone Samsung Galaxy Y (Android smart phone) Nokia C2-00 (Java enabled dual SIM card feature phone)
Accessories Solar lamp (Sun King Pro) with multiple phone charging pins Solar lamp (Sun King Pro) with multiple phone charging
pins
Software ‘InSCALE APE CommCare app’ providing audio and images for
each step in the sick child assessment process. Individual patient
data is synchronised with an online database, and aggregated
patient data and drug stock reports are submitted on a weekly
basis.
‘inSCALE Mobile VHT system’ to send aggregated weekly
reports on patients seen (sex, mRDT results, symptoms and
classification of signs, treatment given and outcome of
treatment) and current drug stock levels.
Respiratory rate application where user presses the centre
button for each breath observed during one minute added
to the phone tool box.
Respiratory rate application where user taps the screen for each
breath observed during one minute built into the electronic
algorithm.
Feedback
messages
Off-line decision support for diagnosis, treatment and referral
provided at the end of the consultation process.
Relevant and personalised feedback messages based on
submitted data sent instantly after reports are received.
Supervisor support Automated weekly and monthly reports are emailed to health
facility and district supervisors on APE activities, suggesting
targeted follow-up actions.
Automated SMS sent to supervisors flagging problems and
strengths identified in the data submitted, and alerting
supervisors about VHTs requiring targeted supervision.
Trained as trainers and in effective supervision skills using
paper based core competency assessment tools
Supervisors’ phones programmed with an electronic checklist
related to core APE competencies linked to an APE Performance
Checklist.
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The community engagement approach aims to en-
hance the perceived value of the CHW, both for them-
selves and for the communities they serve, through
inclusive and participatory local activities. The actions of
health club members will help communicate to the
CHW and village members that their work is important,
of value and appreciated. In doing so, village health
clubs (VHCs) will improve the status and standing of
CHWs as key village health assets, increasing their mo-
tivation and the quality of service provision. VHCs will
also increase the community’s understanding of what
CHWs can and cannot do and their potential to improve
child health in the village. This increased understanding
could mean that a greater demand for CHW services
and, correspondingly, an increase in the number of chil-
dren accessing them. The training of CHWs to facilitate
the health clubs will reinforce and add to skills acquired
during iCCM training and may also improve quality of
care. VHCs will hopefully become valued forums, in-
creasing the capacity of both the CHW and the village
inhabitants to address health issues in their communities
and ensure children are receiving timely, effective and
appropriate treatment.
There is also a possibility that both interventions could
lead to substantial engagement of community members
with child health issues, over and beyond what could be
reasonably attributed to their relationship with CHWs.
In this scenario, improved care-seeking will not only be
due to increased CHW motivation and retention, but
also to enhanced community knowledge and action for
child health. This process will be captured through the
alternative mechanism outlined in Figure 4.
Overview of trial design
The inSCALE interventions are being evaluated through
cluster randomised controlled trials (cRCTs) in Uganda
and Mozambique. The clusters are sub-counties in
Uganda and districts in Mozambique, and correspond to
the lowest administrative units where CHW services are
coordinated, with an average of 60 VHTs and 18 to 25
APEs per cluster, respectively. In Uganda, there are 95
clusters in the eight study districts. In order to be eli-
gible for randomisation, a cluster had to have CHWs
trained in iCCM by 31 January 2011 (3 months before
starting the baseline survey). Clusters that had less than
ten villages or that were participating in another Malaria
Consortium mobile phone pilot study were excluded.
Overall 41/95 clusters were eligible for randomisation.
In Uganda, the trial consists of a three-arm cRCT with
13 clusters in each arm; two clusters were not
Figure 4 inSCALE conceptual framework.
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randomised and were designated as spare/back-up clus-
ters in case of the need to drop one of the selected 39.
In Mozambique, there are 12 clusters, allowing a two-
arm cRCT.
The trial planning started in April 2011, and the
inSCALE interventions were developed and fully imple-
mented in the intervention areas by the end of 2012 in
Uganda and by the end of June 2013 in Mozambique. Im-
pact data on the main outcomes was collected in an end-
line household survey after 12 months of implementation
in Uganda (March-May 2014) and will be collected after
18 months of implementation in Mozambique (February
2015). Detailed process, cost and cost-effectiveness evalua-
tions are being carried out in both countries. All data col-
lection is expected to be completed in May 2015, and
results will be available by the later part of 2015.
Randomisation
Restricted randomisation was performed to minimise
the difference between the intervention and control
arms for key indicators of the average proportion of chil-
dren appropriately treated for fever, diarrhoea, and
pneumonia (FDP); VHT motivation (mean); and the
mean (log10) cost of treatment for children with FDP
[19]. The randomisation of clusters to the three arms
was restricted to those randomisation schemes where
there were minimal between-arm differences for these
five key parameters but still allowed adequate numbers
of randomisation schemes, as too few schemes could
elicit selection bias [20].
In Mozambique, appropriate treatment for childhood
FDP could not be measured reliably at baseline due to a
delay in the roll-out of the APE kits containing iCCM
medicines. Attempts to seek care from an APE or a public
facility were chosen as proxy markers for overall appropri-
ate treatment, as these showed the strongest correlation
with appropriate treatment. This was based on an assess-
ment of the relationship between appropriate treatment
with these and other candidate variables using parallel
data from the Uganda baseline survey (where appropriate
treatment was measured), and by assessment of the cluster
averages and variances for several care seeking variables
from the Mozambique dataset itself.
In Uganda, out of 500,000 random allocations of 39
clusters to three arms, 13,683 of the allocations fit all
criteria. After applying a further filter to ensure that all
districts had at least one sub-county in the mHealth
intervention arm, and that at least the larger districts
had a control arm, a final scheme was picked from the
resulting sub-sample of 1,791 allocation schemes. In this
scheme, all districts had at least one sub-county in the
control arm and one in the mHealth intervention arm,
and five out of eight districts also had at least one sub-
county in the participatory community engagement arm
(Figure 5).
Within Mozambique, there were 924 possible unique
ways to sort 12 districts into two groups. In total, 84
schemes from these potential 924 met the all restriction
criteria. A scheme was picked at random from the final 84
schemes, and was thus the final chosen scheme for the
Mozambique study (Figure 6). In both sites, the selected
schemes had no more than a 5% (proportions) or a 0.5
(scores/counts) difference between arms for any param-
eter. Sorting of clusters and random selection of schemes
were carried out in Stata v12.1 (StataCorp, Texas USA).
Intervention areas
The inSCALE interventions as described above were im-
plemented in the 26 sub-counties in Uganda (13 in the
‘mHealth intervention arm’ and 13 in the ‘community
engagement intervention arm’) and in six districts in
Mozambique. All CHWs and children living in these
clusters were potential recipients of the CHW interven-
tion, in addition to having access to routine care currently
available from private and public health services.
Control areas
Children living in the control areas continued to benefit
from the routine Ministry of Health iCCM package pro-
vided by the CHWs who were supported by the national
and sub-national health services with funding from Malaria
Consortium’s CIDA-iCCM project.
Sample size
The sample size calculations, which are based on a cluster
RCT with 13 and 6 clusters per arm in Uganda and
Mozambique, respectively, are based on the main evalu-
ation outcome: the percentage of children receiving appro-
priate treatment during illness episodes for each of
pneumonia, diarrhoea and fever. This is also the outcome
that requires the largest samples, as not all children sur-
veyed will have had a recent illness episode. Inter-cluster
coefficients of variation, baseline appropriate treatment
rates, and prevalences of illness were calculated from data
collected during the baseline surveys in each site and used
in the sample size calculations (assuming a 5% significance
level).
The calculation was based on the formula for compari-
son of proportions, adjusted for cluster effects stated in
equation 7.7 of Hayes and Moulton [21], that is, where k
is the between cluster coefficient of variation:
C ¼ 1 þ zα=2 þ zβð Þ2ð ðπ0ð1 – π0Þ=m
þ π1 1 – π1ð Þ=m þ k2 π02 þ π12ð ÞÞ = π0 – π1ð Þ2 Þ
The number of sick children required/cluster was de-
termined by varying this number in the formula for the
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number of clusters until the number of clusters/arm
equals 13 and 6, respectively [21]. Thus, sampling 155
children per cluster in Uganda would yield enough sick
children to have 90% power to detect a 15% difference in
the appropriate treatment of pneumonia and fever and a
20% difference in diarrhoea between arms. Sampling 390
children per cluster in Mozambique would yield enough
sick children to have 90% power to detect 20% and 25%
differences in appropriate treatment of fever and pneumo-
nia respectively, and 80% power to detect a 25% difference
in appropriate treatment of diarrhoea between arms.
The sample size formula and sampling scheme were
also used to inform the design of the baseline surveys
(which involved surveillance of households, CHWs and
health facilities). At baseline, site-specific data was not
available for k; therefore, a conservative estimate of 0.15
was used to inform the baseline sample size calculations
in both sites. Prevalence values for FDP in the sites were
based on estimates from recent Demographic and Health
Surveys [22,23], Malaria Indicator Surveys [24,25], and in
the case of Mozambique, an Integrated Health Systems
and Child Friendly District Survey by UNICEF [26]. In
Uganda, 3,900 households with children under the age of
5 years were sampled at baseline; of the 6,501 children in
these households, 47% were reported as having had symp-
toms of fever, 11% with diarrhoea and 24% with pneumo-
nia in the two weeks prior to the survey and were thus
eligible for the full household survey questionnaire on
treatment, care seeking, and health practices. In addition,
360 VHTs and the 79 health facilities supporting these
VHTs were also sampled as part of the baseline. In
Mozambique, 2,970 households with children under the
age of 5 years were sampled; of the 4,422 children in these
households, 29.2% were reported as having had symptoms
of fever, 5.2% with diarrhoea and 10.7% with pneumonia in
the two weeks prior to the survey. Data were also collected
from 256 iCCM-trained APEs and the 80 health facilities
to which they reported.
Figure 5 Interventions and control arm clusters in Uganda.
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Impact evaluation
The primary outcome is the change in carer reported ap-
propriate treatment for fever, diarrhoea and pneumonia in
children in households receiving the intervention(s) com-
pared to those in areas with routine iCCM (‘control’
households). A proportion of children will have had two
or more conditions simultaneously. We intend to group
all conditions and assess the ‘use of appropriate drugs for
this episode of illness for all illness episodes by interven-
tion arm. Additionally, the effect of the interventions on
appropriate treatment for each of the three conditions in-
dividually will be established as a way of understanding
the pathways through which the interventions worked.
The main comparison for effect will be obtained from the
measured difference between interventions and control
arms at end-line. Baseline characteristics were used to per-
form restricted randomisation to minimise the difference
between the intervention and control arms on key
indicators.
Secondary outcomes include a number of perform-
ance, retention, motivation, access and cost-effectiveness
outcomes:
1. Mean motivation score (motivation outcome)
2. % CHWs staying in post after 1 year of
implementation (retention outcome)
Figure 6 Intervention and control arm clusters in Mozambique.
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3. % monthly reports complete and submitted on time
(performance outcome)
4. % CHWs with medicine stock-out <1 week each
quarter (performance outcome)
5. % caregivers with sick child in the last 2 weeks who
accessed iCCM treatment (coverage outcome)
6. % caregivers willing to use CHWs (access outcome)
7. % of start-up costs compared to recurring costs of
the intervention packages (cost outcome)
8. Cost per CHW trained (cost outcome)
9. % of start-up costs compared to recurring costs of
the intervention packages (cost outcome)
10.Cost per child who receives appropriate treatment
for each of diarrhoea, pneumonia and fever (cost-
effectiveness outcome)
11.Cost per episode of illness treated correctly (cost-
effectiveness outcome)
12.Cost- per life year gained (LYG) and DALY averted
(cost-effectiveness outcome)
Household, CHWs and health facility surveys
The primary outcome in both sites will be collected
using an end-line household survey administered to the
child’s primary carer. Data will be collected on illness
prevalence, proportion of children who have received
appropriate treatment and on household socio-economic
status. Secondary outcomes, such as CHW performance,
will be assessed in a sample of CHWs using a structured
questionnaire with pre-tested case scenarios and know-
ledge questions administered by a trained research assist-
ant. A motivation tool has been developed and validated
to establish a composite index of CHW motivation. A
health facility questionnaire will be used to collect data
from health facility staff/supervisors on CHW supervision,
support and health system costs.
The quantitative survey questionnaires will be adopted
from the tools used for the baseline survey. These were
developed in an iterative process: i) with the team of re-
searchers in London and Kampala/Mozambique, ii) with
potential field supervisors, and finally, iii) with trainees
of the data collector training. Both the field supervisors
and data collectors will visit local homes under supervi-
sion of a researcher to practice and test the questions
and make revisions. All questionnaires will be written in
English and translated into the local languages (Runyoro,
Luo and Luganda for Uganda and Portuguese for
Mozambique), and the accuracy of the translation will
be checked by back translation into English. Key illness
terminologies and other sensitive expressions will be
translated into the native languages during the training
and provided to the research assistants on a hard copy
which guided them during the interview. Field editing
will be done for consistency and completeness and after
correction, data will be double-entered by trained data
entry clerks into a SQL data management system cap-
able of consistency, range, inter-database checks and
audit trails.
Intention-to-treat analyses
All analyses will be intention-to-treat, and will account
for the cluster-randomised design. Initial crude analyses
will be based on summary measures for each outcome in
each cluster and t-tests will be used to compare each
intervention arm with the control arm. Multivariate
random-effects models, which allow for cluster-specific
constant amounts and work well for normally distributed
outcomes and Poisson outcomes, will be used to assess the
effect of the intervention on retention, motivation and
coverage of appropriate treatment; adjustments will be
made to account for clustering and any imbalances found
between groups at baseline.. Random effects logistic regres-
sion models can be computationally demanding, and can
fail to converge; if this is the case, generalized estimating
equations (GEE) will be used instead if the random effects
are found to be unreliable. The GEE approach modifies
both parameter estimates and standard errors to allow for
clustering and are appropriate where the clusters them-
selves are of no intrinsic interest. According to the analysis
approach proposed [27], random effects models, whatever
the outcome, will be used, only reverting to GEE where
these do not converge.
Record review
During the project cycle, CHW record books will be
reviewed to estimate the proportion of children classified
with diarrhoea, malaria and pneumonia; the mRDT posi-
tivity rate, and frequency and outcome of referral. Drug
stock cards will be reviewed to estimate drug stock-outs.
Supervisor log books will be reviewed for frequency and
content of supervision visits, and reports from district
and health facility staff will be reviewed for CHW reten-
tion. Health facility records will be reviewed for patient
load for health system costs. To estimate costs of CHW
activities, the results of the process evaluation interviews
described below will be combined with data collection
from financial and activity reporting.
Process evaluation and intervention monitoring
Process evaluation (PE), which started approximately
10 months after implementation of the interventions
(January to February 2014 in Uganda and April to May
2014 in Mozambique), aims to identify lessons learned,
successes and challenges and to crystallise best practices
using key informant interviews with CHWs and their
health facility supervisors. In Uganda, 24 VHTs and
eight supervisors in the mHealth intervention, and 24
VHTs and eight supervisors in the participatory commu-
nity engagement intervention in the districts of Buliisa,
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Hoima, Kyegegwa and Masindi were interviewed using
predesigned topic guides. In Mozambique, 33 semi-
structured key informant interviews with 24 APEs and nine
supervisors were conducted in the districts of Inharrime,
Morrumbene and Inhassoro of Inhambane Province. The
qualitative most significant change methodology [28] was
applied during the process evaluation as a way of monitor-
ing changes observed as a result of the iCCM programme,
and the interventions implemented, to document success
stories from community members, CHWs and health
workers. Specifically the process evaluation explored:
1. whether the interventions were delivered as
designed and taken up and utilised as intended.
2. which the context-based factors had an impact on
aspects of work motivation and satisfaction and the
existing approaches to measuring motivation,
instruments that could be adapted to the specific
case of CHWs, best practices and new methods.
3. whether the interventions influenced motivation,
retention, performance and/or other factors.
4. whether increased motivation impacted on
performance and retention, and whether this lead to
children receiving more appropriate treatment.
5. how the programme was implemented, how the
programme operated, the services it delivered, and
the functions it carried out.
Cost and cost-effectiveness evaluation
The cost and cost-effectiveness analyses will take a societal
perspective, assessing the economic impact for all parties
affected by the interventions.
Intervention costs
The costs of the intervention packages will be estimated
both from a financial and economic perspective. Costs
will include direct project expenditure incurred by the
implementing partner, the costs borne by the MoH at
the national and local level during the implementation
phase, the value of the work time contributed by the
volunteering CHWs in Uganda, and any non-reimbursed
out-of-pocket costs incurred by the CHWs in relation to
their work. In order to allow generalisability of the find-
ings to other contexts, cost will be categorised by principal
inputs and activities, with quantities and values collected
separately as far as possible.
Household and community costs
Direct (out-of-pocket) costs as well as indirect costs
(value of lost production) for households in relation to
care and treatment-seeking will be measured at the end
of the intervention trials across trial arms. Direct costs
will include transport costs, out of pocket payments to
service providers, and any money spent on items
complementary to treatment. Indirect costs will focus on
the time spent caring for the sick child and seeking care.
Costs will be broken down by socioeconomic status.
Health facility costs
It is likely that resource use in local health facilities will
be affected by the introduction of a new level of health-
care worker; due to changes in the numbers of children
seeking care at the health centres, of severe cases seen
due to early treatment in the community, and of cases
referred. The unit costs of treating the illnesses included
in the iCCM package at different facility levels will be
estimated, including staff time, drugs, diagnostics and
other consumables and the use of equipment and facil-
ities. The costs per episode of care in different facilities
will be brought together with health seeking behaviour
information from the household survey to assess the net
difference in resources use.
Cost-effectiveness analysis
The cost-effectiveness analysis will assess the incremen-
tal cost and outcomes of the two intervention and con-
trol arms in Uganda, and between the intervention arm
and control arm in Mozambique. Incremental costs will
be derived from the cost analyses above, combining unit
costs with data on service provision/ utilisation from the
trial surveys in each arm. Outcome measures will be
based in the principal outcome measure of the interven-
tion trial, the incremental difference in the number of
sick children appropriately treated during the trial
period. This outcome will then be converted into life-
years gained (LYGs) and disability- adjusted life years
(DALYs) averted using standard methods.
Informed consent
Individual informed consent is being obtained from all
respondents throughout the projects’ data collection
phases. Information sheets containing information about
the study are provided (or in the case of phone inter-
views, e-mailed in advance) in local languages (Luganda,
Luo, Runyoro/Rutoro or Portuguese (in Mozambique)).
Respondents are given time to read the information
sheet, and key points are summarised verbally and ques-
tions answered. Agreement to participate is indicated by
signature or for phone interviews through verbal con-
sent. The individual’s right to refuse consent or to stop
the interview at any time after consent has been given is
preserved; individuals are not required to provide ex-
planation for such decisions. Stakeholders are asked
whether they consent to the inclusion of verbatim
quotes in reports and for their name to be included in
the list of interviewed persons. Confidentiality of all data
collected is maintained at all times, except where it re-
lates to routine monitoring of performance of CHWs.
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All CHWs are identified by a unique ID number. No
hazardous substances or medical procedures are used in
this study.
Trial monitoring
The project has a nine-person Technical Advisory
Group (TAG) to facilitate dissemination and uptake of
any findings within Uganda and Mozambique, as well as
to provide technical support. Members include influen-
tial experts and national stakeholder representatives,
WHO and UNICEF representatives and advisers with
expertise in public health and community-based re-
search, iCCM, health policy analysis, and international
health policy development. It is also attended by the
principle investigators and members of the inSCALE
study group.
The Data Monitoring and Ethics Committee (DMEC)
has five external members with expertise in health econ-
omy, child health, epidemiology, iCCM and randomised
controlled trials, chosen to provide guidance to the trial
in respect of study design, data analysis and study safety.
The DMEC is responsible for reviewing and evaluating
data with respect to the effectiveness of the supervision/
motivation interventions. Both committees met at the
start of the project to examine trial conduct and progress
and to advise the inSCALE technical team, and will meet
again in the final year of the project. The DMEC is not
carrying out any interim analyses, as the inSCALE inter-
vention does not involve any drugs or medical procedures
and as the evaluation is based on outcomes occurring over
a period of just one year.
Ethical approval
The trial protocol was approved by Makerere University
Institutional Review Board in Uganda, the Uganda Na-
tional Council of Science and Technology (ref. HS 958),
the Comité Nacional de Bioética para a Saúde in
Mozambique (ref. 331/CNBS/12) and London School of
Hygiene & Tropical Medicine Ethics Committee in the
UK (ref. 5762). In addition, approval was obtained from
the district authorities and local leaders in the communi-
ties where the study is being conducted. The study has
been registered as a randomised controlled trial with
http://www.clinicaltrials.gov (identifier NCT01972321).
Discussion
For child health interventions like iCCM to have impact
when implemented at scale, it is crucial that cost-effective
strategies that improve performance and motivation of
CHWs are identified and evaluated in a ‘real-life’ health
systems context. The current, multi-country, cluster ran-
domised controlled trial aims to meet this need by asses-
sing two innovative approaches using mHealth and
participatory community engagement to increase CHW
support, supervision and motivation in Uganda and
Mozambique. We hypothesise that both interventions can
lead to improvements in coverage of appropriate treat-
ment for children with diarrhoea, pneumonia and malaria
(primary outcome) and CHW retention rate, motivation
and performance (secondary outcomes).
This study’s strength is that, as well as drawing on the-
oretical perspectives and evidence of best practices, it
applies a user-centred design to the innovations based
on extensive formative research. In so doing the poten-
tial for innovations to be acceptable, feasible and scalable
is increased by prioritising evidence generated from the
operating context through exploration of needs as stated
by intended users (CHWs and national stakeholders).
The multidisciplinary research team is an additional
strength that enables the application of robust methods
for both qualitative and quantitative evaluation of the
innovations, as well as high quality implementation. A
further strength is the development of an economic
model, parameterised for each country using data from
iCCM implementation, the inSCALE intervention trial,
and secondary data sources, to support policy decisions
in the study countries.
The lack of an accurate measurement to estimate
coverage of appropriate treatment of sick children is one
weakness of the study. Coverage of maternal, neonatal
and child health (MNCH) interventions are typically
monitored through household surveys, which estimate
treatment rates based on 2-week recall of illness symp-
toms by caregivers. However, these survey tools identify
children with reported symptoms, and for illnesses like
pneumonia where the true prevalence in community set-
tings is low, this methodology does not provide an accur-
ate denominator of cases for monitoring treatment rates
[29]. Issues with recall of diagnostic results and treatments
provided have also been documented [30,31]. While we
are aware of these limitations, we attempted to increase
the validity of our estimates by increasing the recall period
to 4 weeks to increase the number of recent cases detected
in the survey, and including an expanded list of symptoms
indicative of pneumonia in order to increase the specificity
of the pneumonia case definition. We also used drug
charts to increase the validity of reported treatments.
Another possible weakness of the study is the lack of
control over contextual factors and other changes in
the health system in which the innovations are imple-
mented. While this was anticipated and attempts are
made to access district and provincial operational plans
and internal project reports, lack of data on factors that
may mediate the effect of the interventions [32], such
as drug stock-outs, health staff rotation, and concurrent
programme implementation by other partners, leaves
us unable to plot these influences with absolute confidence
in their accuracy.
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If evidence yields support for cost-effective innovations
that can generate a highly motivated and well-performing
workforce of CHWs, there is potential for sustainable
coverage of high quality iCCM at scale and significant re-
ductions in child morbidity and mortality.
Public engagement and dissemination
The inSCALE study is designed to directly influence policy
and practice, especially for government-led scale-up of
iCCM in the two countries. Implementation has been
carried out in close consultation with policy makers. In
addition, study materials and early results will be made ac-
cessible on the project website (www.malariaconsortium.
org/inscale) well before the final evaluation is made. There
has been close documentation of all implementation steps,
challenges, innovations and experiences. In addition, the
study employs a rigorous economic modelling for iCCM
implementation in the two countries, in order to provide
directly support to the iCCM policy agenda.
Trial findings will be shared promptly with the local
district health teams and local dissemination meetings
with the study populations will be held. Policy briefs will
be prepared and circulated nationally and internationally
to relevant policy and donor organisations, and national
workshop held to discuss the findings, lessons learnt
concerning implementation and policy implications.
Trial findings will also be disseminated in national and
international scientific meetings, and peer-reviewed pub-
lications will be produced on the impact of the interven-
tion on appropriate treatment of sick children, cost and
cost-effectiveness of the interventions, impact on CHW
motivation and performance, and process outcomes and
lessons learned concerning the interventions evaluated.
Selected stories generated for the most significant change
methodology will be disseminated to policy makers, imple-
menters and the general public using audio-visual and
written messages.
Trial status
The implementation of the interventions in Uganda is
completed and end-line survey data has been collected.
Mozambique is continuing implementation until April
2015. Final evaluation results will be available April 2015
for Uganda and September 2015 for Mozambique.
Abbreviations
ACT: Artemisinine-based combination treatment; APE: agentes polivalentes
elementares; CHW: community health worker; CIDA: Canadian International
Development Agency; DMEC: data monitoring and ethics committee;
FPD: fever, pneumonia and diarrhoea; GEE: generalized estimating equations;
iCCM: integrated community case management; inSCALE: Innovations at
Scale for Community Access and Lasting Effects; mHealth: Mobile Health;
MoH: Ministry of Health; mRDT: Malaria Rapid Diagnostic Test; ORS: Oral
Rehydration Therapy; PE: Process Evaluation; RCT: randomised controlled trial;
TAG: technical advisory group; UNICEF: United Nations Children’s Fund;
VHC: Village Health Club; VHT: Village Health Team; WHO: World Health
Organisation.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
KK, DS, ZH, JT, BK and SM conceived the study; KK, DS, ZH, JT, BK, AV and SM
identified the innovative solutions for the interventions; DS and ZH designed
and implemented the formative research for feasibility and acceptability; KK,
DS, ZH, SS, RL, FK, AV, JT, BK, and SM designed and implemented the
process evaluation; SS, RL, FK, AV and BK designed and implemented the
cost and impact evaluations. KK coordinated the study and drafted the first
version of the paper. All authors read and approved the final manuscript.
Acknowledgements
Funding for this study was provided by the Bill & Melinda Gates Foundation.
inSCALE also benefited from funding support from the DFID Programme
Partnership Agreement (DFID-PPA). We also extend our thanks to the
Ministries of Health in Uganda and Mozambique, and their technical working
groups for iCCM and APEs. Special thanks to the technical advisory group
(TAG) and data, monitoring and evaluation committee (DMEC) members,
and to the inSCALE implementation team: Faruk Aboobakar, Godfrey
Ayebale, Benson Bagorogoza, Juliao Banze, Fenias Benhane, Eleni Capsaskis,
Ana Cristina Castel-Branco, Juliao Condoane, Edmound Kertho, Patrick
Lumumba, Sarah Marks, Abel Muiambo, Maureen Nakirunda, Agnes Nanyonjo
and Nelson Salomao.
Author details
1Malaria Consortium, Development House, 56-64 Leonard Street, London
EC2A 4LT, UK. 2Department of Public Health Sciences, Tomtebodavägen 18A,
Karolinska Institutet, 17177 Stockholm, Sweden. 3Department of
Epidemiology and Biostatistics, School of Public Health, Makerere University
College of Health Science, PO box 8045, Kampala, Uganda. 4Institute for
Global Health, University College London, 30 Guilford Street, London WC1N
1EH, UK. 5Department of Population Health, London School of Hygiene and
Tropical Medicine, London, UK. 6Malaria Consortium Africa, Plot 25 Upper
Naguru East Road, Kampala, Uganda. 7Department of Global Health and
Development, London School of Hygiene and Tropical Medicine, Keppel
Street, London WC1E 7HT, UK.
Received: 28 October 2014 Accepted: 17 March 2015
References
1. Liu L, Oza S, Hogan D, Perin J, Rudan I, Lawn JE, et al. Global, regional, and
national causes of child mortality in 2000–13, with projections to inform
post-2015 priorities: an updated systematic analysis. Lancet. 2015;385:430–40.
2. Jones G, Steketee RW, Black RE, Bhutta ZA, Morris SS. How many child
deaths can we prevent this year? Lancet. 2003;362:65–71.
3. Young M, Wolfheim C, Marsh DR, Hammamy D. World Health Organization/
United Nations Children’s Fund joint statement on integrated community
case management: an equity-focused strategy to improve access to essential
treatment services for children. Am J Trop Med Hyg. 2012;87(5 Suppl):6–10.
4. Mukanga D, Tibenderana JK, Peterson S, Pariyo GW, Kiguli J, Waiswa P, et al.
Access, acceptability and utilization of community health workers using
diagnostics for case management of fever in Ugandan children: a cross-
sectional study. Malar J. 2012;11:121.
5. Bank W. World Development Report: Investing in Health. Oxford: Oxford
University Press; 1993.
6. Tulenko K, Møgedal S, Afzal MM, Frymus D, Oshin A, Pate M, et al. Community
health workers for universal health-care coverage: from fragmentation to
synergy. Bull World Health Organ. 2013;91:847–52.
7. Berman PA, Gwatkin DR, Burger SE. Community-based health workers: head
start or false start towards health for all? Soc Sci Med. 1987;25:443–59.
8. Lehmann U, Friedman I, Sanders D. Review of the utilisation and
effectiveness of community-based health workers in Africa, A joint learning
initiative: Human resources for health and development. Cape Town:
University of the Western Cape; 2004.
9. Bhattacharyya K, Winch P, LeBan K, Tien M. Community Health Worker
Incentives and Disincentives: How They Affect Motivation, Retention, and
Sustainability. Arlington, Virginia: Basic Support for Institutionalizing Child
Survival Project (BASICS II) for the United States Agency for International
Development; 2001.
Källander et al. Trials  (2015) 16:157 Page 16 of 17
10. Uganda MOH. Integrated Community Case Management of Childhood
Malaria, Pneumonia and Diarrhoea: Implementation Guidelines. Kampala:
MOH/WHO/UNICEF; 2010.
11. Simon S, Chu K, Frieden M, Candrinho B, Ford N, Schneider H, et al. An
integrated approach of community health worker support for HIV/AIDS and TB
care in Angonia district, Mozambique. BMC Int Health Hum Rights. 2009;9:13.
12. Mozambique MOH. Programa de Revitalização dos Agentes Polivalentes
Elementares. Maputo: MISAU; 2010.
13. Kallander K, Kertho E, Sinyangwe C, Ntebeka B, Counihan C. Managing acute
febrile illness in the community. American Society of Tropical Medicine and
Hygiene. Washington DC, US: Malaria Consortium; 2013.
14. Kallander K, Tibenderana JK, Akpogheneta OJ, Strachan DL, Hill Z, ten Asbroek
AH, et al. Mobile health (mHealth) approaches and lessons for increased
performance and retention of community health workers in low- and
middle-income countries: a review. J Med Internet Res. 2013;15:e17.
15. Frank T, Källander K. Developing intervention strategies to improve
community health worker motivation and performance. Kampala: Malaria
Consortium; 2012. http://www.malariaconsortium.org/inscale/downloads/
1139-lp-inscale-approaches_ug-mo_oct-2012-lr.pdf. Accessed 20 Feb 2015.
16. Strachan DL, Kallander K, Ten Asbroek AH, Kirkwood B, Meek SR, Benton L,
et al. Interventions to Improve Motivation and Retention of Community
Health Workers Delivering Integrated Community Case Management
(iCCM): Stakeholder Perceptions and Priorities. Am J Trop Med Hyg.
2012;87(5 Suppl):111–9.
17. Malaria Consoritum. Reports and publications. 2014. http://www.webcitation.
org/6T0F4wpjn. Accessed 20 Feb 2015.
18. Dahlgren L, Emmelin M, Winkvist A. Qualitative Methodology for
International Public Health. Umeå: Epidemiology and Public Health Sciences,
Umeå University; 2007.
19. Ivers NM, Halperin IJ, Barnsley J, Grimshaw JM, Shah BR, Tu K, et al.
Allocation techniques for balance at baseline in cluster randomized trials: a
methodological review. Trials. 2012;13:120.
20. Moulton LH. Covariate-based constrained randomization of group-randomized
trials. Clin Trials. 2004;1:297–305.
21. Hayes RJ, Moulton LH. Cluster Randomised Trials (Chapman & Hall/CRC
Interdisciplinary Statistics). USA: Chapman and Hall/CRC; 2008.
22. Ministerio da Saude (MISAU), Instituto Nacional de Estatística (INE), ICF
International (ICFI). Moçambique Inquérito Demográfico e de Saúde.
Calverton, Maryland, USA: MISAU, INE e ICFI; 2011.
23. Uganda Bureau of Statistics (UBOS), ICF International Inc. Uganda
Demographic and Health Survey 2011. Kampala, Uganda: UBOS and
Calverton, Maryland: ICF International Inc; 2012.
24. Ministerio da Saude (MISAU), World Health Organisation, US Agency for
International Development, Centres of Disease Control, Satellife Project,
Department for International Development et al. National Malaria Indicator
Survey, Mozambique (MIS-2007). Maputo, Mozambique: National Malaria
Control Programme; 2007.
25. Uganda Bureau of Statistics (UBOS). Uganda Malaria Surveillance Project,
National Malaria Control Programme, ICF Macro. Uganda Malaria Indicator
Survey 2009. Kampala, Uganda: Ministry of Health; 2010.
26. UNICEF Mozambique. Survey: Integrated Health Systems and Child-Friendly
Districts Maputo. UNICEF: Mozambique; 2008.
27. Kirkwood BR, Sterne JAC. Essential Medical Statistics. Massachusetts:
Blackwell Science Inc.; 2003.
28. Dart J, Davies R. A Dialogical, Story-Based Evaluation Tool: The Most
Significant Change Technique. Am J Eval. 2003;24:137–55.
29. Campbell H, El Arifeen S, Hazir T, O’Kelly J, Bryce J, Rudan I, et al. Measuring
coverage in MNCH: challenges in monitoring the proportion of young
children with pneumonia who receive antibiotic treatment. PLoS Med.
2013;10:e1001421. doi: 10.1371/journal.pmed.1001421.
30. Eisele TP, Silumbe K, Yukich J, Hamainza B, Keating J, Bennett A, et al.
Measuring coverage in MNCH: accuracy of measuring diagnosis and
treatment of childhood malaria from household surveys in Zambia. PLoS
Med. 2013;10:e1001417.
31. Fischer Walker CL, Fontaine O, Black RE. Measuring coverage in MNCH: current
indicators for measuring coverage of diarrhea treatment interventions and
opportunities for improvement. PLoS Med. 2013;10:e1001385.
32. Kok MC, Kane SS, Tulloch O, Ormel H, Theobald S, Dieleman M, et al. How
does context influence performance of communityhealth workers in
low- and middle-income countries? Evidence fromthe literature. Health
Res Pol Syst. 2015;13:13.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Källander et al. Trials  (2015) 16:157 Page 17 of 17
